{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:20:27Z","timestamp":1790734827306,"version":"4.1.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The triglyceride-glucose (TyG) index, a simple surrogate marker of insulin resistance, has been associated with adverse cardiovascular outcomes. However, data on its prognostic value in elderly patients with acute decompensated heart failure (ADHF) are limited. This study aimed to evaluate the predictive role of the TyG index for one-year all-cause mortality in geriatric ADHF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective single-center study included 149 patients aged \u226565 years who were hospitalized with ADHF between January 2023 and December 2024. The TyG index was calculated as ln [fasting triglyceride (mg\/dL)\u2009\u00d7\u2009fasting glucose (mg\/dL)\/2]. Patients were stratified into quartiles based on TyG levels, and outcomes were compared across groups. Receiver operating characteristic (ROC) curves, Kaplan\u2013Meier survival analysis, and multivariate Cox regression were applied to evaluate the prognostic performance of the TyG index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Higher TyG quartiles were significantly associated with increased glucose, triglyceride, and inflammatory marker levels (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). ROC analysis demonstrated moderate discriminative ability for one-year mortality (AUC\u2009=\u20090.72, 95% CI: 0.61\u20130.83,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), with an optimal cut-off value of 8.70. Kaplan\u2013Meier curves showed significantly reduced survival in the highest TyG quartile (45.9%) compared with the lowest (89.5%) (log-rank\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). Although TyG was not an independent predictor in multivariate analysis (HR 1.68; 95% CI: 0.70\u20134.00;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.25), it was significant in the subgroup with left ventricular ejection fraction &amp;lt;40% (HR 1.91; 95% CI: 1.02\u20133.59;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04). Adding the TyG index to a conventional risk model including age, sex, left ventricular ejection fraction, hypertension, chronic obstructive pulmonary disease, cardiovascular disease, and chronic kidney disease significantly improved prognostic accuracy (NRI\u2009=\u20090.273, IDI\u2009=\u20090.011, both\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated TyG levels are associated with increased one-year mortality and reduced survival in elderly ADHF patients. The TyG index provides incremental prognostic value beyond conventional risk factors and in daily clinical practice may serve as a simple, low-cost tool for risk stratification in geriatric heart failure management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1747197","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:17:10Z","timestamp":1774617430000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic value of the triglyceride-glucose Index in elderly patients with acute decompensated heart failure: a one-year mortality analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Ahmet","family":"Yilmaz","sequence":"first","affiliation":[{"name":"Department of Cardiology, Karamano\u011flu Mehmetbey University","place":["Karaman, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"\u00c7i\u00e7ek","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Clinical Gerontology, Konya Sehir Hastanesi","place":["Konya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12933-023-02047-4","article-title":"Association between triglyceride glucose-body mass and one-year all-cause mortality of patients with heart failure: a retrospective study utilizing the MIMIC-IV database","volume":"22","author":"Dou","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12933-023-01973-7","article-title":"Triglyceride-glucose index and heart failure: a systematic review and meta-analysis","volume":"22","author":"Khalaji","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mendia","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.endonu.2014.06.009","article-title":"Triglycerides and glucose index: a useful indicator of insulin resistance","volume":"61","author":"Unger","year":"2014","journal-title":"Endocrinol Nutr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12944-024-02254-2","article-title":"Relationship of the trajectory of the triglyceride-glucose index with heart failure: the kailuan study","volume":"23","author":"Zheng","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/eurjpc\/zwac058","article-title":"Triglyceride-glucose index in the development of heart failure and left ventricular dysfunction: analysis of the ARIC study","volume":"29","author":"Huang","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12933-023-01895-4","article-title":"Association between the triglyceride-glucose index and the risk of mortality among patients with chronic heart failure: results from a retrospective cohort study in China","volume":"22","author":"Zhou","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12944-024-02147-4","article-title":"Association of the triglyceride-glucose index and its related parameters with frailty","volume":"23","author":"Yin","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int"},{"key":"B12","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12944-024-02412-6","article-title":"The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes","volume":"23","author":"Gounden","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/HYPERTENSIONAHA.124.23087","article-title":"Prediabetes increases the risk of frailty in prefrail older adults with hypertension: beneficial effects of metformin","volume":"81","author":"Santulli","year":"2024","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12933-024-02278-z","article-title":"Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults","volume":"23","author":"Cui","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"16478","DOI":"10.1038\/s41598-023-43512-0","article-title":"Triglyceride glucose index as a predictor of mortality in middle-aged and elderly patients with type 2 diabetes in the US","volume":"13","author":"Zhao","year":"2023","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1016\/j.jacl.2024.04.130","article-title":"The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States","volume":"18","author":"Adams-Huet","year":"2024","journal-title":"J Clin Lipidol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","article-title":"Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations","volume":"21","author":"Tao","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.11909\/j.issn.1671-5411.2022.08.006","article-title":"The predictive value of triglyceride-glucose index for in-hospital and one-year mortality in elderly non-diabetic patients with ST-segment elevation myocardial infarction","volume":"19","author":"\u015eayl\u0131k","year":"2022","journal-title":"Journal of Geriatric Cardiology: JGC"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1747197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:17:13Z","timestamp":1774617433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1747197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":18,"alternative-id":["10.3389\/fcvm.2026.1747197"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1747197","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"1747197"}}